Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials
Seokuee Kim,1,2 SeungHwan Lee,1,3 Joo-Youn Cho,1,3 Seo Hyun Yoon,1,3 In-Jin Jang,1,3 Kyung-Sang Yu1,31Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, 2Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, 3Department of Cli...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-11-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/pharmacokinetics-and-tolerability-of-mb12066-a-beta-lapachone-derivati-peer-reviewed-article-DDDT |